Fig. 1From: Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibitionThe different therapeutic approaches which can improve the therapeutic effect of ICIs base therapy, as potential sensitizer, in HCC treatmentBack to article page